Get the app
US › Healthcare

Tiziana Life Sciences Ltd (TLSA)

US · Healthcare · Biotechnology

$1.050.00%
Last close · 2026-10-16

Key statistics

Market cap
$151.4M
Forward P/E
0.0
P/B
2,569.66
Book value
$0.00
EPS (TTM)
$-0.16
52-week high
$2.20
52-week low
$0.76
50-day MA
$1.02
200-day MA
$1.25
Beta
0.44

Analyst view

Analysts rate Tiziana Life Sciences Ltd a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $8.00.

Shareholding

Insiders
47.65%
Institutions
1.91%

Largest institutional holders

FundStake
Dauntless Investment Group, LLC0.91%
Mid-American Wealth Advisory Group, Inc.0.25%
Zhang Financial LLC0.10%
The Goldman Sachs Group Inc0.09%
Citadel Advisors Llc0.06%
The Colony Group LLC0.06%
Geode Capital Management, LLC0.06%
UBS Group AG0.06%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Tiziana Life Sciences Ltd — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.